Advertisement
Singapore markets closed
  • Straits Times Index

    3,224.01
    -27.70 (-0.85%)
     
  • Nikkei

    40,369.44
    +201.37 (+0.50%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Bitcoin USD

    69,768.96
    -799.82 (-1.13%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow

    39,807.37
    +47.29 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • FTSE Bursa Malaysia

    1,536.07
    +5.47 (+0.36%)
     
  • Jakarta Composite Index

    7,288.81
    -21.28 (-0.29%)
     
  • PSE Index

    6,903.53
    +5.36 (+0.08%)
     

Chemours (CC) Extends Capacity to Meet Customers' Needs

The Chemours Company CC recently announced a capacity investment in its Opteon 1100 foam blowing agent and Opteon SF33 specialty fluid, both of which have a low global warming potential (GWP). The expansion will triple the capacity of the ultra-low GWP hydrofluoroolefin (HFO) solution, allowing customers and value chain partners to satisfy the rising demand for HFO-1336mzzZ-based fluids.

Chemours has agreed to produce an additional amount of HFO-1336mzzZ in a deal with Zhejiang Juhua Group, Ltd. It anticipates that startup will commence in late 2025, with full-scale production beginning in early 2026. Zhejiang Juhua Group, Ltd. manufactures and sells fluorochemical materials, fine fluorochemicals, basic chemicals, fertilizers and pesticides, as well as other chemical goods.

Access to this technology can help achieve both sustainability and performance targets across construction, electronics, appliances, vital cleaning, carrier fluid and many other applications as consumers and regulators worldwide seek step-change reductions in CO2 emissions, CC noted.

Chemours offers a portfolio of HFO-1336mzzZ-based products that are more environmentally friendly than non-HFO alternatives. Thermal and shelf-life stability, nonflammability, a low boiling point and formulation flexibility are all advantages of these products. Furthermore, the chemical formulation offers foam producers increased insulating value, more precise application control and a broader application window.

Shares of CC have lost 33.8% over the past year compared with a 12.1% decline of its industry.

Zacks Investment Research
Zacks Investment Research


Image Source: Zacks Investment Research

The company, on its first-quarter call, reiterated its guidance for adjusted EBITDA and free cash flow for 2023. It anticipates adjusted EBITDA for the year to be between $1.20 and $1.30 billion and free cash flow of more than $350 million, including about $400 million in capital expenditures.

The Chemours Company Price and Consensus

The Chemours Company Price and Consensus
The Chemours Company Price and Consensus

The Chemours Company price-consensus-chart | The Chemours Company Quote

Zacks Rank & Key Picks

Chemours currently carries a Zacks Rank #3 (Hold).

Better-ranked stocks to consider in the basic materials space include Koppers Holdings Inc. KOP, AngloGold Ashanti Limited AU and Linde plc LIN. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Koppers currently carries a Zacks Rank #2 (Buy). The Zacks Consensus Estimate for current-year earnings for KOP is currently pegged at $4.40, implying year-over-year growth of 6.3%. It has a trailing four-quarter earnings surprise of roughly 13.64%, on average. KOP has gained around 10.8% in a year.

AngloGold Ashanti currently carries a Zacks Rank #1. The Zacks Consensus Estimate for AU’s current-year earnings has been revised 22% upward in the past 60 days. The consensus estimate for current-year earnings for AU is currently pegged at $1.94, indicating year-over-year growth of 50.4%. AngloGold Ashanti’s shares have popped roughly 31.8% in the past year.

Linde currently carries a Zacks Rank #2. The Zacks Consensus Estimate for LIN’s current-year earnings has been revised 3.8% upward in the past 60 days. Linde beat the Zacks Consensus Estimate in each of the last four quarters. It delivered a trailing four-quarter earnings surprise of 6.9% on average. LIN’s shares have gained roughly 8% in the past year.

ADVERTISEMENT

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

AngloGold Ashanti Limited (AU) : Free Stock Analysis Report

Koppers Holdings Inc. (KOP) : Free Stock Analysis Report

Linde PLC (LIN) : Free Stock Analysis Report

The Chemours Company (CC) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research